Tag Archives: TXMD

Top Undervalued Stocks To Buy Right Now

There are a number of great companies in the market today. The ModernGraham valuation model selected some of the most undervalued Canadian companies. Each company has been determined to be suitable for the Defensive Investor or the Enterprising Investor according to the ModernGraham approach.

Defensive Investors are defined as investors who are not able or willing to do substantial research into individual investments, and therefore need to select only the companies that present the least amount of risk. Enterprising Investors, on the other hand, are able to do substantial research and can select companies that present a moderate (though still low) amount of risk. Each company suitable for the Defensive Investor is also suitable for Enterprising Investors.

Celestica Inc. (TSX:CLS)

Celestica is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, low current ratio, insufficient earnings stability or growth over the last 10 years and the poor dividend history. The Enterprising Investor is only concerned with the lack of dividends. As a result, all Enterprising Investors should feel comfortable proceeding with the analysis.

Top Undervalued Stocks To Buy Right Now: Baker Hughes Incorporated(BHI)

Advisors’ Opinion:

  • [By Wayne Duggan]

    While Loop maintains a Buy rating on all of the stocks mentioned above, Guggenheim analyst Michael LaMotte isn’t quite so bullish on the sector. Earlier this week, LaMotte downgraded the following oil services stocks from Buy to Neutral:

    Baker Hughes Incorporated (NYSE: BHI)
    Fairmount Santrol Holdings Inc (NYSE: FMSA)
    Helmerich & Payne, Inc. (NYSE: HP)
    Nabors Industries Ltd. (NYSE: NBR)
    Schlumberger Limited. (NYSE: SLB)
    Halliburton
    Superior Energy Services

    Guggenheim also cut its 2017 oil price forecast from $55 to $48/bbl.

  • [By Ben Levisohn]

    Evercore ISI’s James West and team are starting to feel really good about the potential of the General Electric (GE)-Baker Hughes (BHI) merger. They explain why:

  • [By Brian Wu]

    GE recently doubled down on its oil and gas business after merging it with Baker Hughes (NYSE:BHI) and took a majority 62.5% stake in the merged entity. The merged entity is now the second-largest oil services business and will help GE take full advantage of increased oil and gas production under the new administration.

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

Top Undervalued Stocks To Buy Right Now: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Nielsen Holdings PLC (NYSE: NLSN) which traded down over 9% at $33.99. The stocks 52-week range is $33.90 to $45.73. Volume was 11.3 million compared to the daily average volume of 3.8 million.

Top Undervalued Stocks To Buy Right Now: Silicon Laboratories Inc.(SLAB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Top Undervalued Stocks To Buy Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Low Price Stocks To Watch Right Now

Following billionaire investor Warren Buffett into stocks he owns has often been a profitable strategy over the past few decades. But reversing the orderbuying a stock before Buffett buys itcan potentially be even more rewarding.

Quiz: How Well Do You Really Know Warren Buffett?

With that in mind, we went prospecting for companies that Berkshire Hathaway (BRK-B, $137), Buffetts holding company, has been buying recently, and four stocks that Buffett doesnt hold but we think he ought to buy. We looked for the things he favors: com颅panies that are leaders in their industries, that have a strong commitment to sharing profit with investors, and whose stocks sell for relatively low prices compared with earnings and underlying asset value.

A few caveats: First, even Buffett makes mistakes. Second, many of Berkshires picks are now made by Buffetts two investing deputies, Todd Combs and Ted Weschler, not Buffett himself. And third, anyone guessing which stocks might be attractive to Berkshire is doing just thatguessing.

Top 10 Low Price Stocks To Watch Right Now: KongZhong Corporation(KZ)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Low Price Stocks To Watch Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Low Price Stocks To Watch Right Now: Seaboard Corporation(SEB)

Advisors’ Opinion:

  • [By John Udovich]

    Thanksgiving is almost here but the exit of both Pilgrim’s Pride Corporation (NYSE: PPC) and Smithfield Foods (NYSE: SFD) to focus on their chicken or pork businesses (the latter was also acquired by the Chinese) leaves just two big Thanksgiving turkey stocks, Hormel Foods Corporation (NYSE: HRL) and Seaboard Corporation (NYSEAMEX: SEB), for investors to consider. According to the American Far Bureau, a 16-pound turkey will (on average) come in at a total of $22.74 this year or roughly $1.42 per pound for a decrease of 2 cents per pound or a total of 30 cents per whole turkey, compared to 2015. The price drop may be a transition back to the norm as the significant bird flu outbreak last year hurt the nations supply of both turkey and eggs.

  • [By John Udovich]

    Thanksgiving is almost here and aside from featuring a turkey, most Thanksgiving dinners will include items from a range of consumer stocks including Campbell Soup Company (NYSE: CPB), Kraft Heinz Co (NASDAQ: KHC), Fresh Del Monte Produce Inc (NYSE: FDP) and McCormick & Company (NYSE: MKC) along with aThanksgiving turkey from Hormel Foods Corporation (NYSE: HRL)or Seaboard Corporation (NYSEAMEX: SEB). According tothe American Farm Bureau Federation,a classic Thanksgiving dinner will cost$49.87 for a gathering of 10 orjust under $5 per person down from 2015s all-time high of $50.11.

  • [By Ashley Moore]

    Here is a table of the 10 most expensive stocks trading on U.S. markets today:

    Company (Ticker)Price per ShareMarket CapBerkshire Hathaway Inc. (NYSE: BRK-A)$ 257,227.52$ 419.50 billionSeaboard Corp. (NYSEMKT: SEB)$ 3,760.00$ 4.48 billionNVR Inc. (NYSE: NVR)$ 1,944.23$ 7.19 billionThe Priceline Group Inc. (Nasdaq: PCLN)$ 1,727.94$ 80.82 billionMarkel Corp. (NYSE: MKL)$ 978.51$ 13.78 billionWhite Mountains Insurance Group Ltd. (NYSE: WTM)$ 935.01$ 4.25 billionAmazon.com Inc. (Nasdaq: AMZN)$ 846.08$ 408.27 billionAlphabet Inc. (Nasdaq: GOOGL)$ 844.06$ 582.85 billionAutoZone Inc. (NYSE: AZO)$ 744.26$ 21.04 billionIntuitive Surgical Inc. (Nasdaq: ISRG)$ 735.63$ 28.41 billion

Top 10 Low Price Stocks To Watch Right Now: Geo Group Inc (The)(GEO)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Corrections Corporation of America (NYSE: CXW) was trading up 7.8% at $20.97 shortly before Monday’s closing bell. GEO Group Inc. (NYSE: GEO) was up 2.2% at $31.29.

  • [By Shanthi Rexaline]

    Height Securities said in a note that the recent drama surrounding Sessions, known as a friend to the industry, has scared the wits out of investors in Corecivic Inc (NYSE: CXW) and The GEO Group Inc (NYSE: GEO).

  • [By Wayne Duggan]

    If a potential Trump impeachment appears to be progressing, traders should watch for potential buying opportunities in the following places:

    U.S. companies with primarily domestic exposure and the SPDR S&P 500 ETF Trust (NYSE: SPY).
    Bank stocks and the Financial Select Sector SPDR Fund (NYSE: XLF).
    Prison stocks Corecivic Inc (NYSE: CXW) and The GEO Group Inc (NYSE: GEO).
    Energy and coal stocks, including the Market Vectors Coal ETF (NYSE: KOL).

    __________

Top 10 Low Price Stocks To Watch Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’ll be listening for news coming from Celgene (CEL) , Amgen (AMGN) , Allergan (AGN) , an Action Alerts PLUS holding, and Regenron (REGN) , all of which are set to present. Of the four, Cramer said he’s sticking with Allergan and Amgen.

Top 10 Low Price Stocks To Watch Right Now: AU Optronics Corp(AUO)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Corning Incorporated in a steady uptrend since we recommended the stock while Universal Display Corporation (NASDAQ: OLED) has taken off even higher and LG Display Co Ltd (NYSE: LPL) and AU Optronics Corp (NYSE: AUO) have given a similar performance:

Top 10 Low Price Stocks To Watch Right Now: ADA-ES Inc.(ADES)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap emissions solutions stock Advanced Emissions Solutions, Inc (NASDAQ: ADES) as a potential long/bullish trade:

Top 10 Low Price Stocks To Watch Right Now: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

Top 10 Low Price Stocks To Watch Right Now: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, financial shares slipped by 0.55 percent. Meanwhile, top losers in the sector included Greenhill & Co., Inc. (NYSE: GHL), down 11 percent, and SVB Financial Group (NASDAQ: SIVB), down 8 percent.

  • [By Jim Robertson]

    For investors with a long memory, the Iridium communications service was launched on November 1, 1998 only for the founding company to go into Chapter 11 bankruptcy nine months later as the cost of service was prohibitive for many users. Iridium Satellite LLC was eventually merged with a special purpose acquisition company (GHQ) created by the investment bank Greenhill & Co. (NYSE: GHL) in September 2009 to form Iridium Communications.

Top 10 Low Price Stocks To Watch Right Now: Gibraltar Industries, Inc.(ROCK)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell by 0.82 percent. Meanwhile, top losers in the sector included Gibraltar Industries Inc (NASDAQ: ROCK), down 9 percent, and Yamana Gold Inc. (USA) (NYSE: AUY), down 9 percent.

10 Stocks to Buy for Surefire Gains in 2018 and Beyond

With everyone looking ahead now to 2018, investors are getting bombarded with ideas regarding the best stocks to buy.

Everyone has their own suggestion about which stocks are going to hit the big time in the coming months, but fear not! Here we have a list of 10 sure-fire winners that tick all the boxes. These stocks to buy are not purely subjective. Instead, they have big support from the Street’s top analysts and the upside potential to match based on the average analyst price target.

I found these stocks using a nifty Top Analyst Stocks tool on TipRanks. This pulls up stocks with bullish recent ratings from multiple top analysts. Scanning through this list, I was able to identify 10 top stocks that make compelling investing opportunities right now. Just to note, I purposefully eliminated stocks that only have big upside potential because share prices are plummeting.

With that in mind, let’s dive in and see which stocks make the cut for 2018:

Stocks to Buy: Micron (MU) Stocks to Buy: Micron (MU)investorplace.com/wp-content/uploads/2017/09/mumsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/09/mumsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/09/mumsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/09/mumsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/09/mumsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/09/mumsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/09/mumsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/09/mumsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/09/mumsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/09/mumsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Over the last three months, semiconductor stock Micron Technology, Inc. (NASDAQ:MU) has received a whopping 19 buy ratings and just 3 hold ratings. As a result, the stock has a ‘Strong Buy’ analyst consensus rating. These analysts believe (on average) that Micron has big upside potential of over 30% from the current share price. This would take MU from $44.12 all the way to $57.65. Bear in mind, MU has already doubled year-to-date!

Five-star Rajvindra Gill assigned a buy rating to MU with a very confident $76 price target on Dec. 20 (72% upside). He says the market is undervaluing MU and he sees serious potential in: 1) 3D NAND transition, which generates a significant cost advantage (30%-35%); and 2) technology limitations in DRAM supply growth.

“We believe investors are focusing too heavily on a NAND pricing decline to see the big picture. With another record quarter and guide (beat revenue and EPS consensus by 5.6% and 11.4%, respectively) in the bag, Micron is on track to generate quarterly EPS of nearly $2.50 or roughly $10 per share of annualized earnings” said Gill on Dec. 20.

Note that this is a top analyst worth following. He is ranked No. 43 out of over 4,700 analysts tracked by TipRanks.

Stocks to Buy: Spark Therapeutics (ONCE)

Stocks to Buy: Spark Therapeutics (ONCE)investorplace.com/wp-content/uploads/2017/08/oncemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/08/oncemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/08/oncemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/08/oncemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/08/oncemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/08/oncemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/08/oncemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/08/oncemsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/08/oncemsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/08/oncemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

Spark Therapeutic Inc’s (NASDAQ:ONCE) innovative gene therapy has just received a critical approval from the Food and Drug Administration. Excitingly, this is the first gene therapy to restore sight to individuals with a rare inherited eye disease that can cause blindness. The treatment, known as Luxturna, can treat both children and adults. Following the news, three analysts quickly reiterated their Spark buy ratings.

“Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer,” said FDA commissioner Scott Gottlieb. “This milestone reinforces the potential of this breakthrough approach in treating a wide range of challenging diseases.”

Overall this ‘Strong Buy’ stock has a bullish average analyst price target of $73 (38% upside potential). We don’t know the drug’s price just yet, but Phil Nadeau, a top Cowen & Co analyst, says: “$500,000 per procedure is reasonable for a once-per-lifetime therapy that has the potential to be curative.”

Meanwhile, Raymond James’ Reni Benjamin notes that: “1) with no negative surprises, the label is slightly better than expected, only excluding the use of this gene therapy in infants under 12 months of age; 2) Spark also received a Rare Pediatric Disease Priority Review Voucher, which we estimate is worth approximately $125 million based on recent transactions.”

Stocks to Buy: Alcoa (AA) Stocks to Buy: Alcoa (AA)investorplace.com/wp-content/uploads/2016/06/aamsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/06/aamsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/06/aamsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/06/aamsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/06/aamsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/06/aamsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/06/aamsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/06/aamsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/06/aamsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Josh Hallett via Flickr (Modified)

Pennsylvania-based Alcoa Corp (NYSE:AA) is the world’s sixth largest producer of aluminum with locations all over the world. The stock is catching the attention of investors following a bullish upgrade from Credit Suisse. On Dec. 20, five-star Credit Suisse analyst Curt Woodworth ramped up his price target from $42 to $61. This now suggests 22% upside potential from the current price. Woodworth is anticipating that tighter aluminum supply will push up prices due to alumina and bauxite closures.

“We note three smelters curtailed production last week, and the government is set to sharply increase inspections in January. We expect the aluminum market to tighten into late 1Q-18 as downstream demand sharply recovers.” Plus, China’s increased commitment to environmental policy will further curtail supply according to Woodworth.

Overall, AA has a ‘Strong Buy’ rating, with only buy ratings from top analysts in the last three months. At the same time, the average analyst price target of $60 stands at 20% upside from the current share price.

Stocks to Buy: MasTec (MTZ) Stocks to Buy: MasTec (MTZ)investorplace.com/wp-content/uploads/2017/01/mtzmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/01/mtzmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Keep a close eye on Florida-based specialty contractor engineer MasTec, Inc. (NYSE:MTZ) in 2018. The company’s work spans electric power infrastructure, oil and natural gas pipelines, renewable energy facilities and wireless networks. Strength across the board has resulted in 100% Street support with seven analysts publishing recent buy ratings. Indeed, MTZ has received no hold or sell ratings from the Street for over 8 months.

“We reiterate a BUY on MTZ ahead of what we expect to be increasing 2018 estimates and an expanding multiple. With all segments poised for growth in 2018, a more diversified positive top line performance is likely to be enhanced on the bottom line by better Oil and Gas margins and a generally improving pricing and mix environment from large projects” writes top Canaccord Genuity analyst Robert Burleson. His buy rating comes with a $58 price tag (15% upside). We can also see that he has an incredible track record on his MTZ ratings with a 100% success rate and 51.6% average return.

Stocks to Buy: TherapeuticsMD (TXMD) Stocks to Buy: TherapeuticsMD (TXMD)investorplace.com/wp-content/uploads/2017/12/txmdmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/12/txmdmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

I have already banged on about TherapeuticsMD Inc (NASDAQ:TXMD) in my recent piece on top healthcare stocks. But this is an intriguing stock pick that I felt was worth including again. TXMD is a unique biotech making waves in the world of female healthcare. The company develops and commercializes products exclusively for women. Its lead product candidate is the TX-004 soft gel capsule for post-menopausal pain. This approach clearly has the backing of the Street, as TXMD has a Strong Buy analyst consensus rating.

In fact, in the last three months, TherapeuticsMD has received seven back-to-back buy ratings. Plus the $15.30 average analyst price target represents a huge 161% upside from the $6 current share price. Crucially, even the lowest price target of $9 from Noble Financial and Deutsche Bank still suggests 55% upside potential.

The most bullish analyst of the pack is top Cantor Fitzgerald analyst William Tanner. He reiterated his TXMD buy rating on Dec. 19 with a $28 price target. Tanner notes that the FDA has opted to conduct a longer Class 2 review of TX-004. But ultimately, he calls the drug ‘an important new therapy’ for atrophy. He says: “We believe the likelihood of approval is high, 85% probability, the highest we use to account for some revenue forecasting uncertainty.”

Stocks to Buy: Amazon (AMZN) Stocks to Buy: Amazon (AMZN)investorplace.com/wp-content/uploads/2016/05/amznmsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-170×93.jpg 170w” sizes=”(max-width: 728px)100vw, 728px” />Source: Mike Seyfang via Flickr

Year-to-date Amazon.com, Inc. (NASDAQ:AMZN) has already soared by 56%. But even with shares at $1,176, we can see that the Street still sees AMZN spiking over 11% to $1,311. In fact, in the last three months this stock has received an eyebrow-raising 33 buy ratings vs. just one hold rating.

The most recent rating comes from top RBC Capital analyst Mark Mahaney. He has just carried out a survey on Amazon’s intelligent personal assistant Alexa. And he likes what he sees. “Following our third annual Alexa survey, we are more impressed with the traction of these devices and more convinced of their potential long-term impact. With tens of millions of users and 20K+ skills, we see Alexa’s value prop as becoming increasingly powerful as awareness and ownership ramp. We think AMZN could see $10-$11B in Alexa-related Rev by 2020.”

In fact, recent reports suggest Alexa made a popular holiday gift. On Christmas Day, Amazon’s Alexa app took the No. 1 spots on both the U.S. Google Play and iPhone App Stores’ free app charts.

Stocks to Buy: Comcast (CMCSA) Stocks to Buy: Comcast (CMCSA)investorplace.com/wp-content/uploads/2016/09/cmcsamsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-170×93.jpg 170w” sizes=”(max-width: 728px)100vw, 728px” />Source: Mike Mozart via Flickr

The cable sector has been down in the dumps, but it is now looking for a comeback in 2018. And there is one company that stands out in particular: mass media king Comcast Corporation (NASDAQ:CMCSA). In the last three months, Comcast scores 10 out of 10, with 10 consecutive buy ratings from the Street. These analysts have an average price target of $45- 10% upside from the current share price.

Top Pivotal Research analyst Jeffrey Wlodarczak is confident that the stock is setup for a solid 2018. On Dec. 19, he told investors: “Recall, our belief that the cable malaise would be winding down by year-end ’17 and we continue to believe that this is the case. Comcast management’s data guidance raise in 4Q, implied material acceleration in capital returns and ’18 cable EBITDA margin expansion helped alleviate these investor fears.”

Plus, he believes that “the elimination of net neutrality laws, which effectively gave regulatory cover for video/phone competitors to freely use the cable plant, should also help with monetization.” His $50 price target translates into 22% upside potential.

Stocks to Buy: Smart Global Holdings (SGH) Stocks to Buy: Smart Global Holdings (SGH)investorplace.com/wp-content/uploads/2017/12/SGHmsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/12/SGHmsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

SGH is a global leader in specialty memory, storage and hybrid solutions for the electronics industry for over 25 years. On the back of a strong beat and raise quarter, three analysts reiterated their Smart Global Holdings Inc (NASDAQ:SGH) buy ratings on Dec. 22. Shares popped 10% on the news. And now these analysts say shares can move another 25% from the current share price to hit $43.

SGH CEO Iain MacKenzie commented that the company enjoyed “strength across the board.” Revenue, gross margin and earnings-per-share all exceeded the high ends of previous guidance. He now has even higher hopes for the coming quarters, due to Brazil and the improving global memory market. Indeed, current strength in Brazil is expected to continue throughout the year as the economy recovers.

Stocks to Buy: Aerie Pharmaceuticals (AERI) Stocks to Buy: Aerie Pharmaceuticals (AERI)investorplace.com/wp-content/uploads/2017/07/biotechmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2017/07/biotechmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Eye disease pharma Aerie Pharmaceuticals Inc (NASDAQ:AERI) received an early holiday gift from the FDA. The US regulatory body has just approved Aerie’s lead product Rhopressa two months ahead of schedule. Aerie is now set to hire a 100-person strong sales force in preparation for launch in 2Q18.

“The FDA has approved Aerie’s Rhopressa drug for the treatment of patients with open angle glaucoma or ocular hypertension. We see this announcement as a positive for the company and also a positive read-through for the potential upcoming approval of Roclatan in 2019,” writes five-star Mizuho analyst Difei Yang.

Intriguingly, she also adds: The approval of Rhopressa reinforces our view that Aerie Pharmaceuticals is a strong takeout candidate.” Yang has an $87 price target on the stock and a very strong AERI track record (86% success rate and 73% average return).

Overall, AERI boasts 100% Street support with 7 buy ratings in the last three months. These analysts believe (on average) that AERI can leap a further 32% in the coming months.

Stocks to Buy: Facebook (FB) Stocks to Buy: Facebook (FB)investorplace.com/wp-content/uploads/2017/11/fbmsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/11/fbmsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/11/fbmsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/11/fbmsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/11/fbmsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/11/fbmsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/11/fbmsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/11/fbmsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/11/fbmsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/11/fbmsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

Social media giant Facebook Inc (NASDAQ:FB) has a big catalyst heading its way for 2018. The company has already premiered its ‘Watch’ tab, but 2018 could be the year where it really takes off. (Of course, this is on top of all the stock’s other catalysts like Instagram, WhatsApp and a new Direct messaging app.)

One of TipRanks’ top 100 analysts, Brent Thrill, believes the ‘Watch’ tab is about to make a sizeable impact on user video consumption. He says the tab will drive video engagement alongside improved network effects and sharing. Plus, Facebook’s data-driven approach to content and partner revenue share agreements is the smart way to go. He is now looking for revenue purely from the Watch tab to hit $12 billion in 2022. Thrill’s $225 price target suggests considerable upside of 27% from the current share price.

Strong Buy stock FB has scored 30 buy ratings and just 1 sell rating in the last three months. Meanwhile, the average analyst price target of $210 indicates 19% upside potential.

TipRanks offers investors the latest insight into eight different sectors by tracking the activity of 4,700 analysts, 5,000 financial bloggers and even 37,000 corporate insiders. As of this writing, Harriet Lefton did not hold a position in any of the aforementioned securities.

Compare Brokers

investment risk

The Trump administration must stay focused despite the seemingly never ending flow of distractions, according to Ohio Governor John Kasich.

The former Republican presidential candidate said the administration must concentrate on its legislative message and avoid the distractions of the Russia investigation and the host of media leaks in the background.

“You have to be able to chew gum and walk at the same time,” Kasich said in an interview with TheStreet TV, adding that it’s probably not possible for the Trump administration to carry on as normal with the slew of media leaks and the Russia investigation in the background. “It’s also important to change the message so we can be talking about tax cuts and economic growth – that’s a good message.”

Trump has been trying to do just that with the unveiling of his budget proposals on Tuesday. 

investment risk: Northrop Grumman Corporation(NOC)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Aggressive military and law enforcement spending could be good news for Northrop Grumman Corporation (NYSE: NOC), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), TASER International, Inc. (NASDAQ: TASR) and Digital Ally, Inc. (NASDAQ: DGLY).

  • [By Rich Smith]

    As details about the Pentagon’s plan have emerged, it’s become clear that this will be a sizable program, amounting to perhaps $1 trillion in spending over 30 years — not just to upgrade the Minuteman missiles, but also to buy new B-21 stealth bombers from Northrop Grumman (NYSE:NOC)and have General Dynamics (NYSE:GD) and Huntington Ingalls (NYSE:HII) design an entirely new class of ballistic missile submarines (to be known as the “Columbia class.”)

  • [By Elizabeth Balboa]

    An official government strategy may open the door for defense contractors beyond the traditional Lockheed Martin Corporation (NYSE: LMT), Northrop Grumman Corporation (NYSE: NOC) and United Technologies Corporation (NYSE: UTX).

investment risk: Mosaic Company (The)(MOS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mosaic (MOS) tumbled to the bottom of the S&P 500 today after announcing that it would buy Vale’s (VALE) fertilizer unit.

    Getty Images

    Mosaicdropped 1.1% to $27.77 today, while the S&P 500 advanced 0.2% to 2,262.53.

    Barron’s Dimitra DeFotis covered the deal over at Emerging Markets Daily:

    Global agricultural chemicals giant Mosaic (MOS) is buying most of the fertilizer chemicals business of Brazilian mining giant Vale (VALE) in a cash-and-stock deal valued at $2.5 billion, but Wall Street doesnt seem to like the deal…

    Vale will maintain an 11% stake with ownership nitrogen and phosphate fertilizing assets in the city of Cubat茫o, Reuters reports. Mosaic adds Canada and Peru mines to its empire as part of the deal, according to the Mosaic acquisition press release…

    Mosaic’s market capitalization fell to $9.7 billion today from $10.4 billion yesterday. It reported net income of $1 billion on sales of $8.9 billion in 2015.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

investment risk: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

investment risk: NeuroMetrix Inc.(NURO)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    NeuroMetrix (NURO) makes and markets wearable neuro-stimulation therapeutic devices. Cash per share is $1.37, with the stock selling more than 20% below that.

investment risk: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Casino Stocks To Own Right Now

Related LVS Macau Might Finally Be Headed In The Right Direction McGregor Vs. Mayweather Superfight Could Be Huge For Las Vegas 'Safe' Consumer Cyclical Dog Retailers And Resorts Romp (Seeking Alpha)
Related MGM Macau Might Finally Be Headed In The Right Direction Cramer Advises His Viewers On Fluor, Bank of America, MGM Resorts And Jack In The Box Casino Stocks Fail To Come Up Trumps (Seeking Alpha)

Most of the time when a company sells an asset to another company, the market rewards the perceived “winner” of the deal and punishes the loser. On rare occasion, the market will see a transaction as a win-win for both parties involved.

Top 10 Casino Stocks To Own Right Now: Visa Inc.(V)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Slower growth with an elevated P/E ratio held back Visa (V) last year. But with growth returning to Visa’s normal levels, we feel it is time to highlight its shares once again.

  • [By Asit Sharma]

    In the past year, PayPal has executed a strategy of forming alliances with potential rivals in the payments space. In a prominent example, last year the company announced a tie-up in the U.S. with card issuer Visa (NYSE:V). Earlier this month, the two parties revealed that they’ve extended the arrangement to the Asia Pacific region. The deal expansion means that banks in the region that issue Visa cards can allow their cardholders to check out online wherever PayPal is accepted. Brick-and-mortar retailers honoring the Visa symbol will now also be able to accept PayPal as payment.

  • [By WWW.KIPLINGER.COM]

    At the top of the list is global payments leader Visa Inc (V).

    Visa sits at the intersection of two of the most powerful trends in the economy today: the rise of the cashless society and the rise of the emerging market consumer. With every passing day, more people around the world are swiping their credit and debit cards in more places. And as the owner of the largest global payments network, Visa sits at the middle of this, like a toll booth operator.

  • [By Brian Feroldi, Dan Caplinger, Travis Hoium, and Matthew DiLallo]

    While we Fools are generally bargain hunters, we recognize that some companies are so fantastic that it can make sense to buy them while they’re on the upswing. With that in mind, we asked a team of Fools to each highlight a stock trading near its 52-week that is still worth buying today. Read on to see why they selected Visa (NYSE:V), Brookfield Infrastructure Partners (NYSE:BIP), Paycom Software (NYSE:PAYC), and Apple (NASDAQ:AAPL).

  • [By The Ticker Tape]

    Overall, first-quarter earnings have been pretty positive and many CEOs struck an optimistic tone discussing outlooks for the remainder of 2017. Two industrial bellwethers, General Electric Company (NYSE: GE) and Honeywell International Inc. (NYSE: HON), just beat Wall Street analyst expectations on Friday and credit card companies American Express Company (NYSE: AXP) and Visa Inc (NYSE: V) also reported strong results—some are taking that as a sign that consumer confidence could be translating into consumer buying. Next up in Q1, Eli Lilly and Co (NYSE: LLY), Lockheed Martin Corporation (NYSE: LMT), and Caterpillar Inc. (NYSE: CAT) report before market open on April 25.

  • [By WWW.THESTREET.COM]

    Not all financial sector stocks are screaming buys right now. In fact, Visa Inc. (V)  is a prominent one that’s showing the opposite type of technical trajectory this week. Visa sold off hard on Monday, declining more than 4% in a move that analysts pinned on investors eschewing card payment companies because of excessive ex-U.S. revenue exposure and the increased attractiveness of actual card issuers, like banks, in a rising rate environment.

Top 10 Casino Stocks To Own Right Now: Bank of the Ozarks(OZRK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Bank Of The Ozarks Inc (NASDAQ: OZRK) reported better-than-expected earnings for its second quarter on Monday.

    Bank of the Ozarks disclosed net income of $54.5 million for the second quarter compared to $44.8 million representing an increase of 21.7 percent. On a per share basis, earnings grew 17.6 percent to $0.60 from $0.51 in the year-ago quarter. This was higher by a penny from the Street analysts' expectations.

Top 10 Casino Stocks To Own Right Now: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Tyler Crowe, Tim Brugger, and Jordan Wathen]

    With that in mind, we asked three of our contributors to highlight a company they will be following closely in the first quarter and why. Here’s what makes Adobe Systems (NASDAQ:ADBE), Charles Schwab (NYSE:SCHW), and U.S. Silica Holdings (NYSE:SLCA) worth following when the next earnings report comes out.

  • [By Dan Caplinger]

    Back in 2009, Charles Schwab (NYSE:SCHW) fired the first shot in the battle of the brokerage companies when it introduced commission-free ETFs to investors. The move ignited a movement among brokers to come up with ETF partnerships, some offering their own funds, while others made deals with existing ETF providers to offer their funds at no commission.

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) had a famous investor selling stock this past week. Chairman Charles Schwab continues to sell stock at an orderly pace. This week the iconic discount brokerage executive sold 600,000 shares at prices between $32.50 and $33.75. The total for the trade came to a whopping $20 million.As we have noted in the past, Schwab is past 80 years old and clearly much of his selling over the years has been for estate planning purposes. The shares traded Friday at $35.25, so a fair amount left on the table.

  • [By Todd Shriber, ETF Professor]

    Vanguard's latest fee cuts answer two such moves this year, including one this month, by rival BlackRock, Inc. (NYSE: BLK) and one fee reduction announcement by Charles Schwab Corp (NYSE: SCHW).

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) also had a famous investor selling stock this past week. The chairman of the company, Charles Schwab, continues to sell stock at an orderly pace. This week the iconic discount brokerage executive and the CEO of the company combined to sell a block of 400,000 shares at prices between $35.43 and $35.46. The total for the trades came to a whopping $14 million.As we have noted in the past, Mr. Schwab is past 80 years old, and clearly much of his selling over the years has been for estate planning purposes. The shares endedFriday at $37.48 so a fair amount left on the table.

Top 10 Casino Stocks To Own Right Now: Omega Healthcare Investors, Inc.(OHI)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Or, consider Omega Healthcare Investors (OHI). The Maryland-based company invests heavily in hospital properties and health care facilities, with a special emphasis on nursing facilities.

  • [By Paul Ausick]

    Omega Healthcare Investors Inc. (NYSE: OHI) dropped about 2.6% Monday to post a new 52-week low of $26.43 after closing at $27.14 on Friday. The 52-week high is $35.14. Volume was around 5.3 million, more than double the daily average of around 2.3 million. The healthcare REIT had now specific news.

Top 10 Casino Stocks To Own Right Now: Fortive Corporation (FTV)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Fortive Corp. (NYSE: FTV) was started as Sector Perform at RBC Capital Markets.

    Herman Miller Inc. (NASDAQ: MLHR) was raised to Market Perform from Underperform at Raymond James.

  • [By Ben Levisohn]

    Last year at this time, we said we can only hope for a bit more growth, and at least bottoming for many of those stubborn energy/commodity/industrial end markets, less FX headwind, pricing support and cost reduction plus smart capital deployment, be it M&A, Capex, and/or buybacks/dividends that might actually lead to stock outperformance. In fact, we did get a bit more growth and many of the stubborn end markets appear to have bottomed, while most of those other items also did play out. The stocks under our coverage outperformed the S&P (which was up >10% itself) by more than 14% on average, led byIngersoll-Rand (+37%),Rockwell Automation (+31%),Eaton (+30%) and Fortive (FTV) (+26%) with Allegion (ALLE) (-2%) andGeneral Electric (+2%) the worst performing.

Top 10 Casino Stocks To Own Right Now: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 20 percent to $7.22. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 17 percent to $7.43. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

Top 10 Casino Stocks To Own Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Casino Stocks To Own Right Now: (MALRF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Casino Stocks To Own Right Now: Coach, Inc.(COH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    …formal language on deal prospects articulates process is proceeding in a timely manner with no definitive timetable and no assurance that process will result in a transaction. We still expect a deal to happen, but do lower our probability from 80% to 70% given the likelihood that potential buyer(s) and KATE have not agreed on a clearing price in earlier rounds of negotiation. We believe a bidder such as Coach (COH) does not want to overpay, is disciplined about managing ROIC, and returns and synergies split may be more rational at an offer price in the range of $22-25. We continue to believe KATE has a long global growth runway ahead with opportunities for store growth abroad, further expansion into non-handbag categories, and supply + digital synergy potential…We rate KATE Market Perform and lower our price target to $21 (was $27). Our updated valuation is based on ~10x our FY18E adj. EBITDA or $284mm.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Ben Levisohn]

    Kate Spade (KATE) caught a bounce on Wednesday when the Wall Street Journalreported that it was actively seeking a buyer. Since then, we’ve learned that the fashion accessories retailer looks set to auction itself off to the highest bidder, with the process potentially beginning next month, with bidders potentially including Coach (COH) and Michael Kors (KORS). In a note today, SunTrust Robinson Humphrey analystPamela Quintiliano and team contend that Kate Spade could fetch as much as $23 a share:

Top 10 Casino Stocks To Own Right Now: InnerWorkings, Inc.(INWK)

Advisors’ Opinion:

  • [By Tom Gentile]

    Now as you can see – and as I mentioned earlier – there’s one that outperforms the others: InnerWorkings Inc. (Nasdaq: INWK):

    INWK is a top marketing firm that services a wide range of Fortune 500 media companies as well as retail, financial, hospitality, automotive, healthcare, and others. It met earnings expectations for the first quarter and fell just short of revenue expectations. Despite that, it’s been steadily climbing: